Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Táňa Macháčková is active.

Publication


Featured researches published by Táňa Macháčková.


Cancer Research | 2015

Abstract 3979: Urinary cell-free microRNAs as potential biomarkers of urothelial carcinoma of the urinary bladder

Jaroslav Juracek; Hana Mlčochová; Michal Staník; Barbora Peltanová; Robert Iliev; Táňa Macháčková; Jitka Mlčochová; Renata Héžová; Jan Doležel; Ondřej Slabý

Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA Introduction: Urothelial carcinoma of the urinary bladder (UCUB) is the most common malignancy of the urinary system. UCUB is divided into muscle invasive and non-muscle invasive bladder cancer (superficial), which represents approximately 80% of cases. Despite the relatively high degree of superficial tumors is UCUB associated with high local recurrence rate and approximately 20% of non-muscle invasive tumors progress to invasive form. Although cystoscopy remains a fundamental investigative tool in the detection and surveillance of urothelial bladder cancer, carcinoma in situ (CIS) or small papillary tumors can be with this method easily missed. This has led to the development of newer technologies and several molecular urinary tests, but currently there is no sensitive biomarker enabling early detection of relapse, which occurs in almost 70% of cases of superficial UCUB or biomarker with ability to predict the risk of progression of non-invasive to invasive form of UCUB. Such requirements could fit with diagnostic approach based on the detection of microRNAs (miRNAs) in urine, where have already showed remarkably high stability and good analytical properties. Patients and methods: Using Affymetrix miRNA microarrays we have analyzed expression profiles of 1733 miRNAs in urine supernatant of 16 UCUB patients (6 invasive, 5 high-grade non-invasive, 5 low-grade non-invasive), 17 controls, 10 RCC patients and 4 urinary tract infections (UTI). Ability of selected miRNAs to identify UCUB from urine was confirmed in the validation phase based on independent cohort of 80 UCUB patients using qRT-PCR method. Results: Global expression profiling revealed set of 76 miRNAs significantly differentially expressed in urine of UCUB patients (P < 0,01) compared to healthy controls, thereof 64 highly up-regulated and 12 down-regulated. These miRNAs were specific for UCUB also when compared to other examined cohorts of patients (RCC, UTI). Moreover 23 miRNAs were able distinguish invasive and non-invasive forms of UCUB (P < 0,01) and 18 miRNAs high-grade and low-grad non-invasive (p < 0,01). Subsequent validation on larger independent cohort of UCUB patients lead to definition of urinary miRNA panel enabling sensitive and highly specific diagnosis of UCUB from urine. Conclusion: Our data have shown that urinary miRNAs could serve as sensitive and specific biomarkers of UCUB and after further independent validations could be useful tool to increase sensitivity of standard cytological examination potentially decreasing high costs for long-term follow-up of UCUB patients. This work has been supported by IGA MZCR: NT/13860-4/2012. Citation Format: Jaroslav Juracek, Hana Mlcochova, Michal Stanik, Barbora Peltanova, Robert Iliev, Taňa Machackova, Jitka Mlcochova, Renata Hežova, Jan Doležel, Ondřej Slabý. Urinary cell-free microRNAs as potential biomarkers of urothelial carcinoma of the urinary bladder. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 3979. doi:10.1158/1538-7445.AM2015-3979


Archive | 2017

Využití RNA sekvenování v identifikaci nových klinicky relevantních biomarkerů – přehled a vlastní výsledky se zaměřením na monitoring akutní rejekce u pacientů po srdeční transplantaci

Jan Novák; Táňa Macháčková; Tereza Káfuňková; Július Godava; Petr Hude; Petr Němec; Helena Bedáňová; Ondřej Slabý; Julie Bienertová Vašků; Jan Krejčí; Lenka Špinarová


Archive | 2017

Změny hladin microRNA ve vzorcích endomyokardiální biopsie během akutní celulární rejekce u pacientů po srdeční transplantaci

Tereza Káfuňková; Jan Novák; Táňa Macháčková; Jiří Šána; Július Godava; Petr Hude; Víta Žampachová; Petr Němec; Helena Bedáňová; Ondřej Slabý; Julie Bienertová Vašků; Jan Krejčí; Lenka Špinarová


European Heart Journal | 2017

P6030Levels of various microRNAs are altered in endomyocardial biopsies during acute cellular rejection in patients after heart transplantation

Jan Novák; Táňa Macháčková; Jiří Šána; Tereza Káfuňková; Július Godava; Petr Hude; Víta Žampachová; Petr Němec; Helena Bedáňová; Ondřej Slabý; Julie Bienertová Vašků; Jan Krejčí; Lenka Špinarová


Archive | 2015

Charakterizace exprese epiteliálních a mezenchymálních markerůzapojených do procesu EMT u pacientů s renálním karcinomem

Hana Mlčochová; Renata Héžová; Táňa Macháčková; Martina Lojová; Alexandr Poprach; Radek Lakomý; Pavel Fabian; Marek Svoboda; Rostislav Vyzula; Ondřej Slabý


Archive | 2015

MikroRNA jako neinvazivní biomarkery renálního karcinomu

Michal Fedorko; Michal Staník; Hana Mlčochová; Táňa Macháčková; Dalibor Pacík; Jan Doležel; Ondřej Slabý


Archive | 2015

Urinary cell-free microRNAs as potential biomarkers of urothelial carcinoma of the urinary bladder

Jaroslav Juracek; Hana Mlčochová; Michal Staník; Barbora Peltanová; Robert Iliev; Táňa Macháčková; Jitka Mlčochová; Renata Héžová; Jan Doležel; Ondřej Slabý


European Urology Supplements | 2015

861 Circulating miRNA-378 and miRNA-210 in patients with renal cell carcinoma and their levels after surgical removal of the tumour

Michal Fedorko; Michal Staník; Robert Iliev; Hana Mlčochová; Táňa Macháčková; Dalibor Pacík; Jan Doležel; Ondřej Slabý


European Urology Supplements | 2015

Urinary cell-free microRNAs as potential biomarkers for bladder cancer

Michal Staník; Jaroslav Juracek; Hana Mlčochová; B. Peltanová; Robert Iliev; Táňa Macháčková; R. Héžová; Jan Doležel; Ondřej Slabý


Archive | 2014

MiRNA-378 a miRNA-210 u pacientů s renálním karcinomem a jejichhladiny po odstranění nádoru

Michal Fedorko; Michal Staník; Robert Iliev; Hana Mlčochová; Táňa Macháčková; Dalibor Pacík; Jan Doležel; Igor Dolan; Ondřej Slabý

Collaboration


Dive into the Táňa Macháčková's collaboration.

Top Co-Authors

Avatar

Ondřej Slabý

Central European Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Hana Mlčochová

Central European Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Renata Héžová

Central European Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Robert Iliev

Central European Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge